Nearly a quarter of all hematology labs analyze more than 100 peripheral blood smears (PBS) every day, yet the vast majority are still performed manually using an optical microscope.
That disturbing statistic is just one creating a growing crisis in the hematology lab.
In the age of widespread digitization in healthcare and across industries, hematology laboratory procedures are falling behind. And it’s that misalignment that planted the seeds of Scopio Labs.
Behind the microscope and behind the times
After witnessing the evolution and power of AI in so many industries, Scopio Labs’ founders wanted to see how they could harness it to make an impact on the world.
As students, they spent a lot of time in hospitals observing laboratory professionals in the hematology lab. And they were stunned to witness how many were still relying on analog, outdated, and labor-intensive practices like counting cells manually and using traditional microscopes.
With their backgrounds in physics, IT, and medical device technology – along with the timely evolution of computer vision – they saw the opportunity to use AI-powered analysis to bring microscopy and hematology into the digital age.
The game-changing digital PBS
Today, Scopio technology is replacing the manual workflow with something infinitely more flexible, scalable, and efficient. Images are delivered in a Google Maps-like interface where the lab technicians and other medical professionals can digitally zoom in and out on the file of the blood sample.
The fully digitized blood sample can be explored, scrolled, and zoomed in and out by the clinician at up to 100x magnification and right to the very fringes of the sample, without missing any details. Scopio has also developed AI-based decision-support solutions to then analyze these digital blood samples.
As a result, Scopio hematology technology eliminates the need to ever go back to the manual microscope. Lab professionals, hematologists, and hematopathologists can securely access full-field digital images and results at 100x resolution from anywhere*.
Empowering the hematology technologist
Full digitization creates the capacity for AI to now suggest the classification of the cells and present them to the user, who can correct what the AI has offered as needed. The user remains in full control.
Scopio’s FDA-cleared, CE-marked Full-Field Peripheral Blood Smear (Full-Field PBS) Application™ supports detection, pre-classification, and pre-quantification for blood cells. Scopio has also launched its CE-Marked Full-Field Bone Marrow Aspirate™ Application in Europe, the first platform to enable a complete digital workflow for bone marrow analysis.
Scopio hematology technology helps alleviate challenges in an industry facing major staff shortages. It increases workflow efficiency by up to 60%, and thereby helps clinicians make treatment decisions faster and initiate treatment sooner.
*Remote review is accessible only for authorized users via the hospital’s secure network.
Get our infographic: The urgent need for full-field cell morphology and the all-digital workflow for more facts on current challenges and new solutions in the hematology lab.